Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who previously received treatment with EXG102-031 in the related study (EXG102-031-111)
- People who have given informed consent and are willing to follow the procedures set out in the study protocol
Who may not be able to join:
- People who are unwilling or unable to take part in long-term follow-up visits or check-ins
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mingwei ZHAO, PhD, Peking University People's Hospital
Phone: +86 13957164092
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
long-term safety：the types, severity, and incidence of serious adverse events (SAEs), adverse events (AEs).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.